Business Context and Reporting Period
Stem, Inc. filed this Form 8-K reporting the completion of its business combination with Star Peak Energy Transition Corp. on April 28, 2021. Star Peak changed its name to Stem, Inc., and Stem became a wholly owned subsidiary of the public holding company, which ceased to be a shell company. Stem provides energy storage and software-related products and services; detailed business information is incorporated by reference from the merger proxy.
Key Financial and Capital Metrics
- PIPE financing: 22,500,000 shares were sold concurrently with the merger at $10.00 per share, generating aggregate gross proceeds of $225.0 million.
- Shares outstanding: Approximately 125,754,510 shares immediately after the merger and PIPE financing; the filing also states approximately 135,424,262 shares issued and outstanding as of the closing date, reflecting subsequent or additional equity issuances described in the filing.
- Warrants and options: Approximately 9,669,752 New Stem options, 12,786,129 public warrants, 7,181,134 private placement warrants, 350,000 RWE warrants exercisable at $0.01 per share, and 23,604 warrants exercisable at $7.07 per share were outstanding. Public and private placement warrants were exercisable at $11.50 per share.
- Redemptions: 19,804 shares were redeemed at approximately $10.13 per share.
- Operating results: This 8-K does not provide clear current-period revenue, profit, cash flow, margin, debt, or liquidity figures. Historical 2019 and 2020 financial statements and unaudited 2020 pro forma information are incorporated by reference.
- Dividends: No cash dividends had been paid, and the company did not expect to pay dividends in the foreseeable future.
Material Changes Versus the Prior Comparable Period
- The transaction converted Star Peak from a shell company into the public holding company for Stem and changed the trading symbols to STEM and STEM WS on the NYSE.
- Stem equity, convertible notes, and certain warrants were converted or exchanged into New Stem securities using a 0.2154 exchange ratio for Stem common stock.
- Founder shares totaling 9,589,626 were converted into New Stem common stock on a one-for-one basis.
- New governance, investor-rights, lock-up, executive employment, and equity incentive arrangements became effective at closing.
- New Stem issued a warrant to RWE for 350,000 shares at $0.01 per share in connection with a strategic relationship agreement.
Guidance, Outlook, Risks, Contingencies, and Unusual Items
- No new financial guidance or quantified operating outlook is provided in this filing.
- Named executive officers received three-year employment agreements, specified base salaries and target bonuses, and substantial initial and prospective restricted stock unit awards.
- Members of management and certain stockholders are subject to a six-month lock-up, subject to customary exceptions. Certain investors also received registration and board nomination rights.
- Management identifies risks involving realization of merger benefits, future financial performance, transaction-related disruption, litigation and product liability, energy costs and regulatory requirements, data privacy and breaches, COVID-19 impacts, and broader economic and operating conditions.
- The filing states that ordinary-course legal proceedings were not expected to have a material adverse effect, individually or in the aggregate, based on information available at filing.
Important Facts to Verify
- Reconcile the stated approximately 125.8 million shares outstanding after the merger and PIPE financing with the later approximately 135.4 million issued-and-outstanding figure.
- Review the incorporated 2020 historical and pro forma financial statements for revenue, losses, cash balances, operating cash flow, debt, liquidity, and transaction accounting effects.
- Assess dilution from approximately 20.3 million public and private warrants, 9.7 million options, the RWE warrant, and other outstanding warrants.
- Review the merger-related ownership, registration, lock-up, and sponsor board nomination provisions.
- Examine executive compensation and restricted stock unit commitments under the new executive agreements and 2020 Incentive Plan.
- Evaluate the assumptions and risk factors supporting any future projections referenced in the merger materials, as this 8-K provides no new quantified guidance.